A calcineurin-independent mechanism of angiogenesis inhibition by a nonimmunosuppressive cyclosporin A analog

Journal of Pharmacology and Experimental Therapeutics

Volumn 338, Issue 2, 2011, Pages 466-475

  Nacev, Benjamin A ^a   Low, Woon Kai ^a,f   Huang, Zhennian ^b   Su, Tina T ^b,g   Su, Zhuang ^b   Alkuraya, Hisham ^c   Kasuga, Dan ^c   Sun, Woong ^c   Träger, Mario ^d   Braun, Manfred ^e   Fischer, Gunter ^d   Zhang, Kang ^c   Liu, Jun O ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b S and T Global Inc   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d MAX PLANCK RESEARCH UNIT FOR ENZYMOLOGY OF PROTEIN FOLDING   (Germany)

^e HEINRICH HEINE UNIVERSITY   (Germany)

^f ST JOHN'S UNIVERSITY   (United States)

^g Philips Academy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CYCLOPHILIN; CYCLOPHILIN INHIBITOR; CYCLOSPORIN A DERIVATIVE;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG TARGETING; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; PRIORITY JOURNAL;

ANGIOGENESIS INHIBITORS; ANIMALS; CALCINEURIN; CELL PROLIFERATION; CELLS, CULTURED; CYCLOSPORINE; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JURKAT CELLS; MALE; MICE; MICE, INBRED C57BL; MICE, NUDE;

EID: 79960475065     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.111.180851     Document Type: Article

References (40)

1. Armesilla AL, Lorenzo E, Gómez del Arco P, Martínez- Martínez S, Alfranca A, and Redondo JM (1999) Vascular endothelial growth factor activates nuclear factor of activated T cells in human endothelial cells: a role for tissue factor gene expression. Mol Cell Biol 19:2032-2043. (Pubitemid 29098261)
2. Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA, Brunskill EW, Sayen MR, Gottlieb RA, Dorn GW, et al. (2005) Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434:658-662. (Pubitemid 40488559)
3. Basso E, Fante L, Fowlkes J, Petronilli V, Forte MA, and Bernardi P (2005) Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D. J Biol Chem 280:18558-18561. (Pubitemid 41379552)
4. Benelli U, Ross JR, Nardi M, and Klintworth GK (1997) Corneal neovascularization induced by xenografts or chemical cautery. Inhibition by cyclosporin A. Invest Ophthalmol Vis Sci 38:274-282. (Pubitemid 27085683)
5. Borel JF, Feurer C, Gubler HU, and Stähelin H (1976) Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions 6:468-475.
6. Bram RJ, Hung DT, Martin PK, Schreiber SL, and Crabtree GR (1993) Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location. Mol Cell Biol 13:4760-4769. (Pubitemid 23220381)
7. Carmeliet P (2003) Angiogenesis in health and disease. Nat Med 9:653-660.
8. Colgan J, Asmal M, Neagu M, Yu B, Schneidkraut J, Lee Y, Sokolskaja E, Andreotti A, and Luban J (2004) Cyclophilin A regulates TCR signal strength in CD4+ T cells via a proline-directed conformational switch in Itk. Immunity 21:189-201. (Pubitemid 39094049)
9. Crabtree GR and Clipstone NA (1994) Signal transmission between the plasma membrane and nucleus of T lymphocytes. Annu Rev Biochem 63:1045-1083. (Pubitemid 24218655)
10. Daum S, Schumann M, Mathea S, Aumüller T, Balsley MA, Constant SL, de Lacroix BF, Kruska F, Braun M, and Schiene-Fischer C (2009) Isoform-specific inhibition of cyclophilins. Biochemistry 48:6268-6277.
11. Dyer BW, Ferrer FA, Klinedinst DK, and Rodriguez R (2000) A noncommercial dual luciferase enzyme assay system for reporter gene analysis. Anal Biochem 282:158-161. (Pubitemid 30409441)
12. Fischer G, Wittmann-Liebold B, Lang K, Kiefhaber T, and Schmid FX (1989) Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 337:476-478.
13. 2+/calcineurin and NFATc3/c4 pattern the developing vasculature. Cell 105:863-875.
14. Hernández GL, Volpert OV, Iñiguez MA, Lorenzo E, Martínez-Martínez S, Grau R, Fresno M, and Redondo JM (2001) Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2. J Exp Med 193:607-620. (Pubitemid 32539557)
15. Ivy SP, Wick JY, and Kaufman BM (2009) An overview of small-molecule inhibitors of VEGFR signaling. Nat Rev Clin Oncol 6:569-579.
16. Jain RK, Duda DG, Clark JW, and Loeffler JS (2006) Lessons from phase III clinical trials on anti-VEGF therapy for cancer. Nat Clin Pract Oncol 3:24-40. (Pubitemid 43108832)
17. Janowski B, Wöllner S, Schutkowski M, and Fischer G (1997) A protease-free assay for peptidyl prolyl cis/trans isomerases using standard peptide substrates. Anal Biochem 252:299-307.
18. Johnson EN, Lee YM, Sander TL, Rabkin E, Schoen FJ, Kaushal S, and Bischoff J (2003) NFATc1 mediates vascular endothelial growth factor-induced proliferation of human pulmonary valve endothelial cells. J Biol Chem 278:1686-1692. (Pubitemid 36801401)
19. Jones CA, London NR, Chen H, Park KW, Sauvaget D, Stockton RA, Wythe JD, Suh W, Larrieu-Lahargue F, Mukouyama YS, et al. (2008) Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability. Nat Med 14:448-453. (Pubitemid 351499393)
20. Kim JS, He L, and Lemasters JJ (2003) Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem Biophys Res Commun 304:463-470. (Pubitemid 36506518)
21. Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, and Schreiber SL (1991) Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66:807-815. (Pubitemid 121001714)
22. Liu JO (2009) Calmodulin-dependent phosphatase, kinases, and transcriptional corepressors involved in T-cell activation. Immunol Rev 228:184-198.
23. Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H, Inohara H, Kubo T, and Tsujimoto Y (2005) Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434:652-658. (Pubitemid 40488558)
24. Nicolli A, Basso E, Petronilli V, Wenger RM, and Bernardi P (1996) Interactions of cyclophilin with the mitochondrial inner membrane and regulation of the permeability transition pore, and cyclosporin A-sensitive channel. J Biol Chem 271:2185-2192. (Pubitemid 26047809)
25. Owens-Grillo JK, Hoffmann K, Hutchison KA, Yem AW, Deibel MR Jr, Handschumacher RE, and Pratt WB (1995) The cyclosporin A-binding immunophilin CyP-40 and the FK506-binding immunophilin hsp56 bind to a common site on hsp90 and exist in independent cytosolic heterocomplexes with the untransformed glucocorticoid receptor. J Biol Chem 270:20479-20484.
26. Papageorgiou C, Borer X, and French RR (1994) Calcineurin has a very tight-binding pocket for the side chain of residue 4 of cyclosporin. Bioorg Med Chem Lett 4:267-272. (Pubitemid 24127119)
27. Passaniti A, Taylor RM, Pili R, Guo Y, Long PV, Haney JA, Pauly RR, Grant DS, and Martin GR (1992) A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest 67:519-528.
28. Rafiee P, Heidemann J, Ogawa H, Johnson NA, Fisher PJ, Li MS, Otterson MF, Johnson CP, and Binion DG (2004) Cyclosporin A differentially inhibits multiple steps in VEGF induced angiogenesis in human microvascular endothelial cells through altered intracellular signaling. Cell Commun Signal 2:3.
29. Rao A, Luo C, and Hogan PG (1997) Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 15:707-747. (Pubitemid 27169297)
30. Rinne A, Banach K, and Blatter LA (2009) Regulation of nuclear factor of activated T cells (NFAT) in vascular endothelial cells. J Mol Cell Cardiol 47:400-410.
31. Rosenwirth B, Billich A, Datema R, Donatsch P, Hammerschmid F, Harrison R, Hiestand P, Jaksche H, Mayer P, and Peichl P (1994) Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog. Antimicrob Agents Chemother 38:1763-1772. (Pubitemid 24250722)
32. Schinzel AC, Takeuchi O, Huang Z, Fisher JK, Zhou Z, Rubens J, Hetz C, Danial NN, Moskowitz MA, and Korsmeyer SJ (2005) Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc Natl Acad Sci USA 102:12005-12010. (Pubitemid 41291119)
33. Sharpe RJ, Arndt KA, Bauer SI, and Maione TE (1989) Cyclosporine inhibits basic fibroblast growth factor-driven proliferation of human endothelial cells and keratinocytes. Arch Dermatol 125:1359-1362. (Pubitemid 19252850)
34. Sigal NH, Dumont F, Durette P, Siekierka JJ, Peterson L, Rich DH, Dunlap BE, Staruch MJ, Melino MR, and Koprak SL (1991) Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A? J Exp Med 173:619-628.
35. Swanson SK, Born T, Zydowsky LD, Cho H, Chang HY, Walsh CT, and Rusnak F (1992) Cyclosporin-mediated inhibition of bovine calcineurin by cyclophilins A and B. Proc Natl Acad Sci USA 89:3741-3745.
36. 2+ and oxidant stress. Eur J Biochem 238:166-172.
37. Tiepolo T, Angelin A, Palma E, Sabatelli P, Merlini L, Nicolosi L, Finetti F, Braghetta P, Vuagniaux G, Dumont JM, et al. (2009) The cyclophilin inhibitor Debio 025 normalizes mitochondrial function, muscle apoptosis and ultrastructural defects in Col6a1-/- myopathic mice. Br J Pharmacol 157:1045-1052.
38. Watson JV, Chambers SH, and Smith PJ (1987) A pragmatic approach to the analysis of DNA histograms with a definable G1 peak. Cytometry 8:1-8.
39. Wissing ER, Millay DP, Vuagniaux G, and Molkentin JD (2010) Debio-025 is more effective than prednisone in reducing muscular pathology in mdx mice. Neuromuscul Disord 20:753-760.
40. 2+-induced release of the transcription factor MEF2. Science 286:790-793.